Prescription Drug Information: Valacyclovir Hydrochloride (Page 8 of 8)

SPL PATIENT PACKAGE INSERT SECTION

.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC # 49483-690-04
Valacyclovir Tablets USP 500 mg
100s count (10×10) unit dose package label

500-carton
(click image for full-size original)

NDC # 49483-690-03
Valacyclovir Tablets USP 500 mg
30s count bottle label
500-30s
(click image for full-size original)

NDC # 49483-690-41
Valacyclovir Tablets USP 500 mg
42s count bottle label

500-42s
(click image for full-size original)

NDC # 49483-690-50
Valacyclovir Tablets USP 500 mg
500s count bottle label

500-500s
(click image for full-size original)

NDC # 49483-691-04
Valacyclovir Tablets USP 1 gm
100s count (10×10) unit dose package label

1gm-carton
(click image for full-size original)

NDC # 49483-691-03
Valacyclovir Tablets USP 1 gm
30s count bottle label

1gm-30s
(click image for full-size original)

NDC # 49483-691-01
Valacyclovir Tablets USP 1 gm
100s count bottle label

1gm-100s
(click image for full-size original)

NDC # 49483-691-50
Valacyclovir Tablets USP 1 gm
500s count bottle label

1gm-500s
(click image for full-size original)

VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49483-690
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VALACYCLOVIR HYDROCHLORIDE (ACYCLOVIR) VALACYCLOVIR 500 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
HYPROMELLOSES
MAGNESIUM STEARATE
FD&C BLUE NO. 2
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 400
POLYSORBATE 80
CARNAUBA WAX
Product Characteristics
Color blue Score no score
Shape CAPSULE Size 18mm
Flavor Imprint Code RDY;552
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49483-690-03 30 TABLET in 1 BOTTLE None
2 NDC:49483-690-41 42 TABLET in 1 BOTTLE None
3 NDC:49483-690-50 500 TABLET in 1 BOTTLE None
4 NDC:49483-690-04 10 TABLET in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079012 07/14/2021
VALACYCLOVIR HYDROCHLORIDE valacyclovir hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49483-691
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VALACYCLOVIR HYDROCHLORIDE (ACYCLOVIR) VALACYCLOVIR 1 g
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
HYPROMELLOSES
MAGNESIUM STEARATE
FD&C BLUE NO. 2
TITANIUM DIOXIDE
POLYETHYLENE GLYCOL 400
POLYSORBATE 80
CARNAUBA WAX
Product Characteristics
Color blue Score 2 pieces
Shape CAPSULE Size 23mm
Flavor Imprint Code RDY;553
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49483-691-03 30 TABLET in 1 BOTTLE None
2 NDC:49483-691-50 500 TABLET in 1 BOTTLE None
3 NDC:49483-691-04 10 TABLET in 1 BLISTER PACK None
4 NDC:49483-691-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079012 07/14/2021
Labeler — TIME CAP LABORATORIES, INC. (037052099)
Registrant — TIME CAP LABORATORIES, INC. (037052099)
Establishment
Name Address ID/FEI Operations
MARKSANS PHARMA LIMITED 925822975 manufacture (49483-690), manufacture (49483-691)

Revised: 07/2021 TIME CAP LABORATORIES, INC.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.